Article info

Download PDFPDF
Prevention of endpoints in primary biliary cholangitis with ursodeoxycholic acid: quantifying the benefit

Authors

  1. Correspondence to Prof. Dr. Jörn M Schattenberg, I. Department of Medicine, University Medical Center of the Johannes Gutenberg University, Mainz 55131, Germany; joern.schattenberg{at}unimedizin-mainz.de
View Full Text

Citation

Schattenberg JM
Prevention of endpoints in primary biliary cholangitis with ursodeoxycholic acid: quantifying the benefit

Publication history

  • Received January 5, 2020
  • Revised March 6, 2020
  • Accepted March 8, 2020
  • First published March 23, 2020.
Online issue publication 
July 07, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.